Login / Signup

Enabling Secure Communication in Wireless Body Area Networks with Heterogeneous Authentication Scheme.

Insaf UllahMuhammad Asghar KhanAko Muhammad AbdullahFazal NoorNisreen InnabChien-Ming Chen
Published in: Sensors (Basel, Switzerland) (2023)
Thanks to the widespread availability of Fifth Generation (5G) wireless connectivity, it is now possible to provide preventative or proactive healthcare services from any location and at any time. As a result of this technological improvement, Wireless Body Area Networks (WBANs) have emerged as a new study of research in the field of healthcare in recent years. WBANs, on the one hand, intend to gather and monitor data from the human body and its surroundings; on the other hand, biomedical devices and sensors interact through an open wireless channel, making them exposed to a range of cyber threats. However, WBANs are a heterogeneous-based system; heterogeneous cryptography is necessary, in which the transmitter and receiver can employ different types of public key cryptography. This article proposes an improved and efficient heterogeneous authentication scheme with a conditional privacy-preserving strategy that provides secure communication in WBANs. In the proposed scheme, we employed certificateless cryptography on the client side and Identity-Based Cryptography on the receiver side. The proposed scheme employs Hyperelliptic Curve Cryptography (HECC), a more advanced variation of Elliptic Curve Cryptography (ECC). HECC achieves the same level of security with a smaller key size and a more efficient approach than its counterpart methods. The proposed scheme not only meets the security and privacy standards of WBANs but also enhances efficiency in terms of computation and communication costs, according to the findings of the security and performance analysis.
Keyphrases
  • healthcare
  • low cost
  • health information
  • visible light
  • global health
  • big data
  • mental health
  • primary care
  • emergency department
  • induced pluripotent stem cells
  • pluripotent stem cells
  • drug induced